SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Cadila Healthcare's US arm to acquire assets of Nesher Pharmaceuticals

18 Jun 2011 Evaluate

Cadila Healthcare’s wholly owned subsidiary Zydus Pharmaceuticals; through its US subsidiary Zynesher Pharmaceuticals USA has entered into an agreement to acquire the asset of the US based Pharmaceutical company Nesher Pharmaceuticals. Nesher operates as the generic subsidiary of KV Pharmaceuticals based at St. Louis. Missouri. USA.

Nesher has substantial expertise in niche therapies which have development or production barriers, such as controlled release medications or FDA controlled substances. With this Zydus will be able to manufacture and distribute generic controlled substances in the American market, which otherwise cannot be imported. The Purchase agreement contains Nisher’s existing and pipeline assets and assumption of certain liabilities. The agreement also covers supply and technical services by which certain products of the KV Pharmaceutical will be manufactured by Zynesher pharmaceuticals USA.

Cadila Pharmaceuticals focuses on various areas, such as formulations (human & veterinary), new drug discovery, novel drug delivery, pharmaceutical ingredients, analytical research, phytochemistry, biotechnology, plant tissue culture, etc.

Zydus Lifesciences Share Price

938.90 -1.20 (-0.13%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×